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Antrodia camphorata is a Taiwanese-specific fungus which has been used clinically
to treat hypertension, immune- and liver-related diseases and cancer; however, it
has never been studied in type 2 diabetes mellitus (T2DM). Hyperglycemia in T2DM
causes endoplasmic reticulum (ER) stress, leading to β-cell dysfunction. During chronic
ER stress, misfolded proteins accumulate and initiate β-cell apoptosis. Moreover,
β-cell dysfunction leads to defect in insulin secretion, which is the key process in
the development and progression of T2DM. Therefore, the aim of the present study
was to examine the effects of A. camphorata on insulin secretion and ER stress-
induced apoptosis in a mouse β-cell line, MIN6, and their underlying mechanisms.
We demonstrated that the ethanolic extract of A. camphorata increased glucose-
induced insulin secretion dose-dependently through peroxisome proliferator-activated
receptor-γ (PPAR-γ) pathway, and upregulated genes that were involved in insulin
secretion, including PPAR-γ, glucose transporter-2 and glucokinase. Furthermore,
A. camphorata slightly increased cell proliferation, as well as protected from ER stress-
induced apoptosis in MIN6 cells. In conclusion, this study provided evidences that
A. camphorata might have anti-diabetic effects and could be a novel drug for T2DM.
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INTRODUCTION
Antrodia camphorata is a Taiwanese-specific fungus, which has been used as traditional medicine
to treat cancer, hypertension and skin itching, and it also has anti-oxidant and anti-inflammatory
effects (Geethangili and Tzeng, 2011). Previous study demonstrated that the aqueous extract
of A. camphorata exhibited hypolipidemic activity and reduced plasma triglyceride levels in
hypercholesterolemic rats (Suk et al., 2008). Other studies also showed that A. camphorata
ameliorated hepatic steatosis, hyperlipidemia and metabolic syndrome in high-fat-diet mice (Chou
et al., 2013; Kuo et al., 2015).
Abbreviations: A. camphorata, Antrodia camphorata; DMEM, Dulbecco’s Modified Eagle’s Medium; ER, endoplasmic
reticulum; GLK, glucokinase; GLUT-2, glucose transporter-2; IRE1α, inositol requiring 1α; MTT, thiazolyl blue tetrazolium
blue; PI, propidium iodide; PPAR-γ, peroxisome proliferator-activated receptor-γ; PPRE, peroxisomal proliferator response
element; RXR, retinoid X receptor; T2DM, type 2 diabetes mellitus; TG, thapsigargin; UPR, unfolded protein response;
XBP-1, X-box binding protein 1.
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Recently, it has been suggested that A. camphorata might
contain PPAR-γ ligands, which resulted in hypotriglyceride
effects (Suk et al., 2008). PPAR-γ belongs to the nuclear receptor
superfamily which is also expressed in β-cells, and it forms
heterodimers with RXR in order to bind to the PPRE on gene
promoters and activates gene transcription (Kim and Ahn, 2004).
It has been reported the presence of PPRE in the GLUT-2
and GLK promoters, which are involved in insulin secretion
(Kim et al., 2000, 2002). Several studies have demonstrated
that PPAR-γ agonists could increase glucose-induced insulin
secretion in primary islets and β-cell lines (Ishida et al., 2004;
Kim et al., 2008; Evans-Molina et al., 2009). However, the effect
of A. camphorata in insulin secretion has not been studied in
pancreatic β-cells.
β-cell dysfunction leads to defect in insulin secretion, which
is the key process in the development and progression of T2DM.
In T2DM, chronic insulin resistance and a progressive decline in
β-cell function result in β-cell apoptosis and dysfunction (Butler
et al., 2003). Therefore, it has been suggested that preserving
β-cell function and mass is an important therapeutical target
for the treatment of T2DM (Buchanan et al., 2002; Del Prato
et al., 2007; Vetere et al., 2014). ER stress is one of the main
causes of β-cell apoptosis and dysfunction in T2DM (Butler
et al., 2003; Prentki and Nolan, 2006; Eizirik et al., 2008). It
is the accumulation of misfolded proteins in the ER, which
activates UPR (Leibowitz et al., 2010), and the UPR prevents
the accumulation of misfolded protein in the cells. The UPR is
regulated by different proteins localized to the ER membrane:
protein kinase R (PKR)-like ER kinase (PERK), IRE1α and
activating transcription factor 6α (ATF6α; Leibowitz et al., 2010;
Back et al., 2012). During chronic ER stress, these pathways fail
to degrade misfolded proteins, which initiate β-cell apoptosis
(Rutkowski et al., 2006).
In this study, we investigated the effects of A. camphorata
on insulin secretion and ER stress-induced apoptosis in a
β-cell line, MIN6. Our results showed that A. camphorata
increased insulin secretion in a dose-dependent manner through




The ethanolic extract of A. camphorata was provided by Biotech
Lantyng Company (Taipei, Taiwan). Cell culture reagents
were obtained from Gibco (USA). GW9662, Rosaglitazone,
and MTT were purchased from Sigma (USA). PPAR-γ
(D69), ki-67 (D3B5) mAb, Caspase-3, β-actin, α,β-Tubulin
and GAPDH antibodies, and anti-rabbit-HRP secondary
antibodies were obtained from Cell Signaling Technology (USA),
while GLK, p-IRE1α (phospho-S724), IRE1α antibodies were
obtained from Abcam (USA). p-PERK (phosphor-Thr981),
PERK (aa947-996) antibodies were purchased from LifeSpan
BioSciences (USA), while GLUT-2 (H-67) and ATF6α (H-280)
antibodies were purchased from Santa Cruz Biotechnology
(USA).
Cell Culture
MIN6 cells were cultured with DMEM highglucose (25 mM)
supplemented with 10% fetal bovine serum and 1% penicillin–
streptomycin, and equilibrated with 5% CO2 and 95% air at
37◦C. The experiments were performed between passages 16
and 24.
Extraction of A. camphorata
The mycelia of A. camphorata were cultured in 1 L of growth
medium containing 0.1 g NaCl, 10 g peptone, 2 g yeast extract,
10 g agar, and 10 g cereal mixture (rice, wheat, and corn), at pH
7.5 and 25◦C for 12–14 weeks. 1 kg of A. camphorata mycelia
were extracted twice with a 10-fold ethanol solution to obtain
two ethanolic extracts by ultrasound-assisted extraction method
at 50◦C. The ethanolic extracts were then concentrated to yield
230 g crude extract.
Glucose-Stimulated Insulin Secretion
The cells were cultured in 24-wells plates with high glucose
DMEM (25 mM), and were treated with A. camphorata
(0–500 ng/ml) for 24 h. GW9662 (50 µM, Tocris Bioscience,
USA), a PPAR-γ inhibitor, was co-treated with A. camphorata for
24 h, and Rosglitazone (50 µM, Sigma–Aldrich, USA), a PPAR-γ
agonist, was used as a positive control. After 24 h of treatment,
the cells were washed twice with Krebs–Ringer bicarbonate
buffer (KRBB: CaCl2 2.5 mM; KCl: 4.7 mM; KH2PO4: 1.2 mM;
MgCl2: 1.2 mM; NaCl: 120 mM; HEPES: 10 mM; NaHCO3:
25 mM; and pH = 7.4) no glucose, and incubated with
KRBB 3 mM glucose for 30 min. The cells were washed twice
with KRBB no glucose before incubating with KRBB 5.5 or
16.7 mM glucose for 1 h. The supernatants were collected
and insulin was measured by mouse insulin ELISA (Mercodia,
USA).
MTT Assay
MTT assay was used to determine cell viability, and TG was
used as an ER stress inducer. The cells were pre-treated with
A. camphorata (0–500 ng/ml) for 24 h, and then were treated
with 1 µM TG for 24 h to induce cell death. MTT (1 mg/ml) was
added to the cells, and was incubated for 4 h. The absorbance was
measured at 570 nm.
Apoptosis Assay
Annexin V–PI staining was used to measure cell apoptosis
by flow cytometry. The cells were incubated with
A. camphorata (0–500 ng/ml) for 24 h, and then were
stimulated with 1 µM TG for 24 h. The staining was
performed according to the manufacturer’s protocol (BD
Biosciences, USA). Annexin V–fluorescein isothiocyanate
(FITC) positive cells were defined as early apoptotic cells,
whereas Annexin V and PI positive cells were defined as late
apoptotic cells. Analyses were performed using FlowJo 7.6.1
software.
Ki-67 Staining
The cells were cultured in 96-wells plates and were treated with
50–500 ng/ml A. camphorata for 24 h. The cells were then fixed
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with fixative for 15 min and permeabilized with 0.5% Triton
X-100 for 10 min. The cells were blocked with 20% donkey
serum for 30 min. Subsequently, the cells were stained with ki-
67 (D3B5) monoclonal antibody (Alexa Fluor 488 conjugate) for
1 h and DAPI (1 µg/ml) for 10 min. Images were taken with
20×magnification by IN Cell Analyser 2000 Imaging System (GE
Healthcare Life Sciences, USA), and were analyzed with Image J
software.
Western Blot Analysis
The cells were either treated with A. camphorata (0–500 ng/ml)
for 24 h only, or were then treated with 1 µM TG for
6 or 24 h. After treatment, the protein was extracted with
ice-cold lysis buffer, and nuclear proteins were extracted
using the Nuclear and Cytoplasmic Extraction Kit (Pierce,
France) for detection of the PPAR-γ antibody only. The
protein concentrations of the lysates were measured by the
bicinchoninic acid kit (Pierce, France). 40–60 µg proteins were
used and separated by 8–10% SDS-PAGE gels, and were then
transferred onto the nitrocellulose membranes. Membranes were
incubated with PPAR-γ, GLUT-2, GLK, Caspase-3, p-IRE1α,
IRE1α, p-PERK, PERK, ATF6α antibodies and anti-rabbit-
HRP secondary antibodies, and blots were developed by
enhanced chemiluminescence (GE Healthcare Life Sciences,
USA) with an imaging system (Bio-Rad Laboratories, USA).
GAPDH, β-actin, and α,β-tubulin were used as housekeeping
controls.
Real-Time PCR Analysis
The cells were treated with A. camphorata (0–500 ng/ml)
for 24 h. After treatment, total RNA was extracted using
RNeasy Mini Kit (Qiagen, USA), and cDNA was synthesized by
reverse transcription. cDNA was quantified using Sybr Green
assays by ViiA 7 Real-Time PCR System (Applied Biosystems,
USA). The primers used were as follows: GLUT-2 (forward:
5′-TCAGAAGACAAGATCACCGGA-3′; reverse: 5′-GCTGGT-
GTGACTGTAAGTGGG-3′), GLK (forward: 5′-TGAGCCG-
GATGCAGAAGGA-3′; reverse: 5′-GCAACATCTTTACACT-
GGCCT-3′), β-actin (forward: 5′-GGCTGTATTCCCCT-
CATCG-3′; reverse: 5′-CCAGTTGGTAACAATGCCATGT-3′).
β-actin was used as an internal control. Gene expressions were
calculated using the 11Ct method, and were normalized to
control.
Statistical Analysis
The results were expressed as mean± SEM (standard error of the
mean). Statistical significance was determined by t-test or one-
way ANOVA followed by Dunnett’s test, using GraphPad Prism
5.0. P< 0.05 was considered as significant.
FIGURE 1 | Antrodia camphorata increased insulin secretion through PPAR-γ in MIN6 cells. The cells were treated with A. camphorata for 24 h, and were
stimulated with Krebs–Ringer bicarbonate buffer (KRBB) 5.5 mM or 16.7 mM glucose for 1 h. (A) Insulin levels were determined using a mouse insulin ELISA kit.
50 µM Rosglitazone (Ros), a PPAR-γ agonist, was used as a positive control, n = 4–6. One-way ANOVA; ∗P < 0.05, ∗∗∗P < 0.001 vs. control with KRBB 5.5 mM
glucose; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. control with KRBB 16.7 mM glucose. (B) The cells were treated with 250 ng/ml A. camphorata in the absence
and presence of 50 µM GW9662 (GW), PPAR-γ inhibitor, n = 5. ∗∗P < 0.01 vs. control with KRBB 16.7 mM glucose; ##P < 0.01. Results were expressed as
mean ± SEM.
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FIGURE 2 | Antrodia camphorata increased PPAR-γ expression and its related protein expressions in MIN6 cells. The cells were treated with
A. camphorata (50–500 ng/ml) for 24 h. (A–C) Immunoblots and representative graphs showing the protein expressions of PPAR-γ, GLUT-2 and GLK, n = 4, 5.
(D,E) Relative gene expressions of GLUT-2 and GLK. The gene expressions were normalised to control, n = 4, 5. ∗P < 0.05, ∗∗∗P < 0.001 vs. control. Results were





Firstly, we investigated the effect of the ethanolic extracts
of A. camphorata on glucose-induced insulin secretion in
MIN6 cells. After treatment with A. camphorata for 24 h,
MIN6 cells were incubated with KRBB 5.5 mM or 16.7 mM
glucose for 1 h, the supernatants were then collected for
insulin ELISA. A. camphorata (50–500 ng/ml) enhanced glucose-
induced insulin secretion dose-dependently in MIN6 cells
(Figure 1A). Rosglitazone, a PPAR-γ agonist, was used as a
positive control. 50 µM Rosglitazone significantly increased
insulin secretion at 16.7 mM glucose (Figure 1A). PPAR-γ has
been shown to be involved in insulin secretion (Ishida et al.,
2004; Kim et al., 2008; Evans-Molina et al., 2009), and it has
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FIGURE 3 | Antrodia camphorata reduced ER stress-induced apoptosis in MIN6 cells. The cells were treated with A. camphorata (10–500 ng/ml) for 24 h
and apoptosis was induced by 1 µM TG for 24 h. (A) MTT assay was performed to measure the cell viability, n = 5. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. TG
only. (B) Cell apoptosis was measured by Annexin V–PI staining using flow cytometry. Annexin V–fluorescein isothiocyanate (FITC) positive cells were defined as early
apoptotic cells, n = 7. ∗P < 0.05 vs. control; #P < 0.05 vs. TG. (C) Representative flow cytometric analyses for Annexin V–PI staining. Results were expressed as
mean ± SEM.
been suggested that A. camphorata might contain PPAR-γ ligands
(Suk et al., 2008), so GW9662, a PPAR-γ inhibitor, was used
to examine whether PPAR-γ was involved in A. camphorata-
induced insulin secretion. With co-treatment of 50 µM GW9662
with 250 ng/ml A. camphorata, insulin secretion was significantly
reduced (Figure 1B).
Antrodia camphorata Increased PPAR-γ,
GLUT-2, and GLK Expressions in MIN6
Cells
Since PPAR-γ was involved in the enhancement of insulin
secretion by A. camphorata, we next examined the nuclear
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FIGURE 4 | Antrodia camphorata decreased caspase-3 expression and slightly increased cell proliferation in MIN6 cells. (A) Immunoblots and
representative graphs showing the protein expressions of cleaved/total caspase-3. The cells were treated with A. camphorata (AC; 10–500 ng/ml) for 24 h and then
stimulated with 1 µM TG for 24 h, n = 4. ∗∗∗P < 0.001 vs. control; #P < 0.05, ##P < 0.01 vs. TG. (B,C) Images and representative graphs showing ki-67 staining.
The cells were treated with 50–500 ng/ml A. camphorata for 24 h, n = 4. Results were expressed as mean ± SEM.
protein expression of PPAR-γ in MIN6 cells. The cells were
treated with A. camphorata (0–500 ng/ml) for 24 h before
protein extraction. 250 and 500 ng/mlA. camphorata significantly
increased nuclear PPAR-γ protein expressions (Figure 2A).
Studies have identified PPRE on the promoter regions of
GLUT-2 and GLK genes, in which PPAR-γ-RXR complex
binds to and upregulates their gene transcriptions (Kim et al.,
2000, 2002). So we also examined the protein and mRNA
expressions of GLUT-2 and GLK. A. camphorata (50–500 ng/ml)
significantly increased GLUT-2 protein expression (Figure 2B),
while it increased GLK protein expression in a dose-dependent
manner (Figure 2C). Furthermore, 500 ng/ml A. camphorata
significantly increased GLUT-2 and GLK mRNA expressions
(Figures 2D,E).
Antrodia camphorata Protected from ER
Stress-Induced Apoptosis in MIN6 Cells
Endoplasmic reticulum stress is one of the main causes that
leads to β-cell apoptosis (Butler et al., 2003; Prentki and
Nolan, 2006; Eizirik et al., 2008), so here we used TG as a
model to induce ER stress and β-cell apoptosis, and examined
the effect of the ethanolic extracts of A. camphorata on ER
stress-induced apoptosis in MIN6 cells. The cells were treated
with A. camphorata (10–500 ng/ml) for 24 h and then were
stimulated with 1 µM TG for 24 h. MTT assay was performed to
determine the cell viability. TG decreased cell viability compared
to control, and with pre-treatment of A. camphorata (50–500
ng/ml), the cell viability significantly increased (Figure 3A).
Notably, the increase in cell viability was 47% at 100 ng/ml
A. camphorata. Annexin V–PI staining was also performed
to measure cell apoptosis, and Annexin V–FITC positive cells
were defined as early apoptotic cells. Similar results were also
demonstrated. TG significantly increased early apoptosis, and
A. camphorata pre-treatment dramatically suppressed the cell
apoptosis (Figures 3B,C). 13% reduction in apoptosis was
observed at 100 ng/ml A. camphorata.
Caspase-3 is another indicator of cell apoptosis, so we next
examined the effect of A. camphorata on caspase-3 expression
by immunoblotting. TG markedly increased cleaved/total
capase-3 expression, and A. camphorata pre-treatment
significantly reduced this expression in a dose-dependent
manner (Figure 4A). As A. camphorata increased cell viability,
so cell proliferation was further investigated by ki-67 staining.
50–500 ng/ml A. camphorata slightly increased ki-67 staining
compared to control (Figures 4B,C).
Antrodia camphorata Protected from
Apoptosis through Downregulation of
IRE1α Pathway in MIN6 Cells
Thapsigargin is an ER stress inducer, which is known to
upregulate UPR responses including IRE1α, PERK, and ATF6α
pathways. Next, we investigated whether these pathways were
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FIGURE 5 | Antrodia camphorata reduced ER stress-induced apoptosis by downregulating IRE1α pathway in MIN6 cells. The cells were treated with
A. camphorata (AC; 10–500 ng/ml) for 24 h and then stimulated with 1 µM TG for 6 h. (A) Immunoblots showing the protein expressions of phospho-IRE1α, IRE1α,
phospho-PERK, PERK, and ATF6α. (B) Representative graphs showing the protein expressions of phospho-PERK/PERK, n = 4. ∗∗P < 0.01 vs. control.
(C) Representative graphs showing the protein expressions of ATF6α, n = 5. (D) Representative graphs showing the protein expressions of phospho-IRE1α/IRE1α,
n = 4. ∗P < 0.05 vs. control; #P < 0.05 vs. TG. Results were expressed as mean ± SEM.
involved in the protection from TG-induced β-cell apoptosis by
A. camphorata. 6 h treatment with TG increased the protein
expressions of phospho-IRE1α/IRE1α, phospho-PERK/PERK,
and ATF6α (Figure 5A). Pre-treatment of A. camphorata
(10–50 ng/ml) reduced the increase in phospho-IRE1α/IRE1α
expression dose-dependently, but not for phospho-PERK/PERK
and ATF6α expressions (Figures 5A–D).
DISCUSSION
Antrodia camphorata has been widely used clinically as
traditional medicines in many diseases such as hypertension, liver
diseases, cancer, and immune-related diseases (Chen et al., 2001;
Geethangili and Tzeng, 2011). Previous studies on A. camphorata
were mostly focused on the anti-cancer, anti-oxidant, anti-
inflammatory, and heptaprotective effects (Dai et al., 2003;
Hsiao et al., 2003; Mau et al., 2004; Shen et al., 2004; Hsu
et al., 2005; Kuo et al., 2006); however, the anti-diabetic effect
has never been studied. T2DM is a metabolic disease which
is characterized by β-cell dysfunction and apoptosis, and it
affects more than 2% of the world population (Day, 2001).
Therefore, we here were the first to examine the effects of the
ethanolic extracts of A. camphorata on insulin secretion and
apoptosis in a mouse β-cell line, MIN6, and the underlying
mechanisms.
In the present study, we first demonstrated that A. camphorata
increased glucose-induced insulin secretion dose-dependently
in MIN6 cells. At 500 ng/ml A. camphorata with 16.7 mM
glucose KRBB stimulation, the increase in insulin secretion was
fivefold higher than control. Rosglitazone, a PPAR-γ agonist,
was used as a positive control, and its insulin secretion was
only 1.2-fold higher than control, therefore it suggested that
A. camphorata might have anti-diabetic effect. Moreover, at basal
glucose level (5.5 mM glucose), 250 and 500 ng/ml A. camphorata
also significantly increased insulin secretion, this suggested
that A. camphorata-induced insulin secretion was dispensable
for glucose response. Furthermore, it has been suggested that
A. camphorata might contain PPAR-γ ligands (Suk et al., 2008),
so PPAR-γ inhibitor, GW9662, was used to investigate whether
PPAR-γ was involved in the enhancement of insulin secretion
by A. camphorata. GW9662 markedly reduced the enhancement
of insulin secretion by A. camphorata, so this suggested that
A. camphorata enhanced insulin secretion through PPAR-γ
pathway. PPAR-γ is a transcription factor which is located in
the nuclear membrane, and it forms heterodimers with RXR
to bind to the PPRE region on promoters and up-regulates
gene transcription (Kim and Ahn, 2004). Activation of PPAR-γ
has been shown to increase intracellular calcium concentration,
which leads to insulin release (Kim et al., 2008, 2013). It has been
shown that GLUT-2 and GLK promoters contain PPRE region,
so PPAR-γ up-regulates GLUT-2 and GLK gene transcription
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(Kim et al., 2000, 2002). Therefore the expressions of PPAR-
γ, GLUT-2 and GLK were also examined. GLUT-2 is a glucose
transporter which helps to uptake glucose into the cells, while
GLK is an enzyme which facilitates the phosphorylation of
glucose inside the cells. Our results showed that A. camphorata
increased nuclear PPAR-γ protein expressions, GLUT-2 and GLK
protein and mRNA expressions in MIN6 cells. Taken together,
this suggested that A. camphorata increased insulin secretion
through PPAR-γ pathway, and upregulated PPAR-γ, GLUT-2 and
GLK expressions in MIN6 cells.
Endoplasmic reticulum stress is one of the main causes
in T2DM, which leads to β-cell apoptosis and dysfunction
(Butler et al., 2003; Prentki and Nolan, 2006; Eizirik et al.,
2008). Cell apoptosis in β-cells is one of the main concerns
in T2DM, and it has been demonstrated that A. camphorata
prevented hepatic cell damage by serving as radical scavengers
(Hsiao et al., 2003; Song and Yen, 2003), and ameliorated liver
damage in animal model of nonalcoholic liver disease with
high-fat-diet (Chou et al., 2013). However, it has not been
studied in β-cell death, so we further investigated the effect of
A. camphorata on ER stress-induced cell death in MIN6 cells. TG
was used as a model to induce ER stress, thus β-cell apoptosis.
Our results demonstrated that A. camphorata pre-treatment
significantly improved the cell viability and reduced TG-induced
early apoptosis. This suggested that A. camphorata could prevent
from ER stress-induced cell death. In addition, A. camphorata
significantly reduced cleaved/total caspase-3 expression, another
marker of cell apoptosis. Taken together, our findings suggested
thatA. camphorata has a protective role against ER stress-induced
apoptosis in MIN6 cells. β-cell dysfunction is one of the main
outcomes in T2DM, and beside from treating T2DM by reducing
β-cell apoptosis, β-cell regeneration also plays an important role
for the treatment of T2DM (Dominguez-Bendala et al., 2012;
Minami and Seino, 2013). Ki-67 is a nuclear protein which is
present in all phases of cell cycle except resting cells, so it is
associated with cell proliferation (Scholzen and Gerdes, 2000). In
addition, ki-67 staining is used commonly as a cell proliferation
marker. Our results demonstrated that A. camphorata slightly
increased cell proliferation in MIN6 cells, so this suggested that
A. camphorata might be potential to enhance cell regeneration in
MIN6 cells. Furthermore, a study showed that the plasma levels
of glucose, leptin, insulin, total cholesterol, and triglyceride were
lowered in high-fat diet mice treated with Ergostatrien-3β-ol
from A. camphorata, and insulin resistance was also attenuated
in these mice (Kuo et al., 2015). Taken together, our study
together with their study suggested that A. camphorata might
have anti-diabetic effects and might be potential for treating
T2DM.
In addition, we also examined the downstream pathways that
were involved in β-cell protection by A. camphorata. During
ER stress, misfolded proteins accumulate in the ER lumen,
which activate UPR and prevents the accumulation of misfolded
proteins (Leibowitz et al., 2010), and UPR is regulated by
IRE1α, PERK, and ATF6α pathways (Leibowitz et al., 2010;
Back et al., 2012). IRE1α is a ER transmembrane kinase,
and during ER stress, it undergoes autophosphorylation which
induces endoribonuclease activity and splices XBP-1 mRNA
that regulates chaperone expressions (Fonseca et al., 2011).
In addition, prolonged activation of IRE1α by high glucose
induced β-cell death (Hou et al., 2008). Herein we showed
that 6 h treatment with TG significantly increased IRE1α,
PERK, and ATF6α pathways. With TG stimulation for 6 h, pre-
treatment with A. camphorata reduced the protein expression of
phospho-IRE1α/IRE1α in a dose-dependent manner, but not for
phospho-PERK/PERK and ATF6α expressions. This suggested
that A. camphorata could protect the cells as early as 6 h by
downregulating IRE1α pathway. These findings were consistent
with other studies suggesting that reducing ER stress could
prevent β-cell death (Song et al., 2008; Zhu et al., 2013).
CONCLUSION
The present study demonstrated, for the first time, the
potentiating effect of A. camphorata on insulin secretion and
the protective effect against ER stress-induced apoptosis in a
mouse β-cell line, MIN6. We demonstrated that A. camphorata
potentiated glucose-induced insulin secretion dramatically
through PPAR-γ pathway, and upregulated genes which were
involved in insulin secretion, including PPAR-γ, GLUT-2, and
GLK. We also provided evidences that it has a protective effect
against TG-induced cell apoptosis. In addition, A. camphorata
was able to slightly increase cell proliferation in MIN6 cells.
Taken together, our findings suggested that A. camphorata has
beneficial effects on improving MIN6 cell function, so it might
have anti-diabetic effects and could be a novel drug for T2DM.
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